Crystallization

Thai Leaf aims for a breakthrough in Thailand’s healthcare industry with its high-quality CBD oil and CBD infused products.

Retrieved on:

Tuesday, May 9, 2023

Simply put, hemp is known for health as opposed to marijuana which is used for recreational purposes.

Key Points:

Simply put, hemp is known for health as opposed to marijuana which is used for recreational purposes.
With the founders' extensive background and experience in both the agricultural and pharmaceutical industry, Thai Leaf's end-game is in pharmaceutical CBD products.
The Thai CBD market is currently worth THB 7 billion, and forecasted to grow to THB 50 billion within the next three years.
Thai Leaf is the first generation company to be licensed in Thailand for hemp derived CBD.

SynCrest Launches CRDMO Service for Peptide-based Therapeutics

Retrieved on:

Monday, May 8, 2023

SynCrest delivers a one-stop service for peptide-based therapeutics, from library synthesis and process development for drug discovery through to manufacturing of experimental medicine for clinical studies, support for new product releases, and on-demand commercial manufacturing.

Key Points:

SynCrest delivers a one-stop service for peptide-based therapeutics, from library synthesis and process development for drug discovery through to manufacturing of experimental medicine for clinical studies, support for new product releases, and on-demand commercial manufacturing.
Regarding nucleic acids, SynCrest has been able to lower costs and dramatically improve purity of the amidites that comprise the raw material.
SynCrest is also actively engaged in research on fluorine-related compounds and is able to introduce fluorine in peptide and nucleotide compounds.
SynCrest has developed an industry-leading continuous flow synthesis method with in-line measurement that enables non-destructive, high-precision measurements in real time.

India Vacuum Pump Market Report 2023: Growing Government and Private Investments Bolster Sector - ResearchAndMarkets.com

Retrieved on:

Thursday, May 4, 2023

The India Vacuum Pump Market is anticipated to grow during the forecast period on the back of investments by the government and companies majorly in the chemical, pharmaceutical, semiconductor & electronics industries.

Key Points:

The India Vacuum Pump Market is anticipated to grow during the forecast period on the back of investments by the government and companies majorly in the chemical, pharmaceutical, semiconductor & electronics industries.
According to the publisher, the India Vacuum Pump Market revenue is projected to grow at a CAGR of 15.5% from 2022-2028.
The rising investment in key application industries would further fuel the India vacuum pump market growth in the forthcoming period.
This sector in India is one of the most vital parts of the Asia Pacific Vacuum Pump Market.

Blueberries Medical Reports 2022 Financial Results

Retrieved on:

Monday, April 24, 2023

Specialization, Crystallization, Distillation, GoTo (US company), Cosmetics, Sale, Accounting, Biomass, THC, Allied Corporation, Cryptocurrency, Airline, Blueberry, LATAM, Serdal, CBD

On August 24, 2022, Blueberries signed a lease termination agreement with SINEA Group, owner of Tocancipa warehouse, generating significant savings for the company.

Key Points:

On August 24, 2022, Blueberries signed a lease termination agreement with SINEA Group, owner of Tocancipa warehouse, generating significant savings for the company.
On October 28, 2022 Blueberries sold the first batch of the new developed product, a CBD Water-Soluble novel specialty for food/beverage and cosmetics.
On October 30, 2022 Blueberries sold the first batch of CBD Broad Spectrum from the revenue share signed in June to Cannfarm Peru SAC.
On December 19, 2022 Blueberries shipped the first batch of CBD Isolate to Australian market, one of the most interesting markets.

Xypex Chemical Corporation Announces the Opening of Xypex India Manufacturing Facility

Retrieved on:

Saturday, April 22, 2023

Delhi Metro, Construction, Crystallization, Fine chemical

Vancouver, BC, Apr 22, 2023 - (ACN Newswire) - Xypex Chemical Corporation, a world leader in construction products for waterproofing by crystallization, is proud to announce the opening of Xypex India and the commissioning of a new production facility in Noida, India.

Key Points:

Vancouver, BC, Apr 22, 2023 - (ACN Newswire) - Xypex Chemical Corporation, a world leader in construction products for waterproofing by crystallization, is proud to announce the opening of Xypex India and the commissioning of a new production facility in Noida, India.
For more than 20 years, Xypex has partnered with its exclusive distributor in India, Apaar Infratech, to establish strong business relationships in private construction markets and government projects.
Xypex is excited to celebrate the opening of its new manufacturing plant, which will enable them to provide innovative concrete waterproofing materials to the Indian construction industry.
Xypex looks forward to building on our strong partnerships with the construction industry in India.

Lummus Announces Successful Startup of World's Largest Double Reslurry Paraxylene Crystallization Unit

Retrieved on:

Thursday, April 20, 2023

Plastic, Partnership, Crystallization, CLG, Dow Chemical Co. v. United States, Engineering, Petrochemical, Lummus, Chemical substance

HOUSTON, April 20, 2023 /PRNewswire/ -- Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced the startup of Shenghong Refining & Chemical (Lianyungang) Co., Ltd.'s 2,800 kMTA paraxylene unit. The grassroots unit, which is the world's largest double reslurry paraxylene crystallization unit, is part of Shenghong's refining and petrochemical integrated project in Lianyungang, Jiangsu Province, China.

Key Points:

HOUSTON, April 20, 2023 /PRNewswire/ -- Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced the startup of Shenghong Refining & Chemical (Lianyungang) Co., Ltd.'s 2,800 kMTA paraxylene unit.
The grassroots unit, which is the world's largest double reslurry paraxylene crystallization unit, is part of Shenghong's refining and petrochemical integrated project in Lianyungang, Jiangsu Province, China.
In 2017, Lummus executed an agreement with Shenghong Refining & Chemical Co. to provide the paraxylene technology license, process design services and operator training and startup services.
Lummus is the exclusive worldwide licensor of INEOS Aromatics' paraxylene technology, a unique process employing stage crystallization for paraxylene recovery.

Rockwell Automation supports environmentally friendly lithium production to secure UK supply

Retrieved on:

Wednesday, April 19, 2023

Lithium, Rockwell Automation, DCS, Filtration, Plant, Digital technology, Crystallization, Automation, NYSE, Cornish Lithium

BRUSSELS, April 19, 2023 /PRNewswire/ -- Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, is working with Cornish Lithium Plc on a demonstration plant to validate the sustainable production of lithium hydroxide from micaceous granite.

Key Points:

The Cornish Lithium demonstration plant will be controlled by the PlantPAx® modern distributed control system from Rockwell Automation.
"Rockwell Automation has both the technology and domain expertise to support the complex lithium extraction process," said Phil Hadfield, UK managing director, Rockwell Automation.
Cornish Lithium has licensed an acid-leaching, selective precipitation, and crystallization process developed to create lithium hydroxide from micaceous granite.
"Rockwell Automation will play quite a crucial role in what we are doing," said David Moseley, process manager, hard rock minerals, at Cornish Lithium.

Analytic Partners Reveals New Brand Identity as Part of Growth Trajectory

Retrieved on:

Tuesday, April 18, 2023

Heart, Crystallization, General counsel, CMO, History, Organization, IHS Markit, Onex Corporation, Growth, MMA, Retail, Industrial design

MIAMI, April 18, 2023 /PRNewswire/ -- Analytic Partners, the leader in commercial analytics, has today announced at MMA POSSIBLE the launch of a new brand identity to build on its recent growth trajectory.

Key Points:

MIAMI, April 18, 2023 /PRNewswire/ -- Analytic Partners, the leader in commercial analytics, has today announced at MMA POSSIBLE the launch of a new brand identity to build on its recent growth trajectory.
The new brand evolves the look and feel of the category-defining brand, bringing a contemporary level of sophistication to align with Analytic Partners' transformation over the past couple of years.
The new brand identity is a vibrant, dynamic system that mirrors Analytic Partners' platform and history as an industry leader.
The brand's evolution reflects the company based on people, platform, and expertise that delivers revenue-driving growth for its customers.

Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques

Retrieved on:

Friday, April 14, 2023

Science, HPMC, Drug development, Crystallization, Therapy, Hydrogen chloride, Metformin, Engineering, Artificial intelligence, Merck, Micronization, Automation, Medical imaging, Pharmaceutical industry

SHENZHEN, China and DARMSTADT, Germany, April 14, 2023 /PRNewswire/ -- Science and technology company Merck and XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, have jointly published a study that highlights the benefits of combining computational workflows with wet lab experiments to advance drug development.

Key Points:

Traditional methods like milling and micronization, used to address undesirable crystal morphologies, can be disruptive and costly.
The collaboration between Merck and XtalPi focused on the impact of different polymer additives on the crystal habit of metformin HCl, a diabetes medication.
Dr. Jan Gerit Brandenburg, Head of Digital Chemistry at Merck, added, "Our collaboration with XtalPi is transforming pharmaceutical development.
By seamlessly incorporating computer simulations with our experimental formulation expertise in a 'digital-first' approach, we are boosting drug development processes and positively impacting patients' lives."

Euro Manganese Produces HPEMM from Chvaletice Demonstration Plant

Retrieved on:

Thursday, April 13, 2023

Demonstration plant, Metal, Czech Republic, Crystallization, ASX, Purification, EMN, Magnetic separation, Plant, Demonstration, Lithium, Renewable energy, Television

VANCOUVER, British Columbia, April 13, 2023 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to confirm it has produced high-purity electrolytic manganese metal ("HPEMM") from its Demonstration Plant (the "Plant") at the Chvaletice Project (the "Project") in the Czech Republic.

Key Points:

VANCOUVER, British Columbia, April 13, 2023 (GLOBE NEWSWIRE) -- Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQX: EUMNF; Frankfurt: E06) (the "Company" or "EMN") is pleased to confirm it has produced high-purity electrolytic manganese metal ("HPEMM") from its Demonstration Plant (the "Plant") at the Chvaletice Project (the "Project") in the Czech Republic.
An external laboratory has confirmed the first HPEMM sent for testing has met the Demonstration Plant target specifications and was at 99.9% Mn metal purity.
Customer deliveries of the Company’s Demonstration Plant products is not expected to be required for completion of offtake contracts.
Representatives from the company which manufactured the Demonstration Plant are expected to arrive on site in late April and the plant will undergo acceptance testing.